Serum resistin level in diabetes mellitus and at high risk of developing coronary heart diseases in Saudi patients

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms by which Elevated Resistin Levels Accelerate Atherosclerotic Cardiovascular Disease

  2013cited by this paper
• Association of resistin with heart failure and mortality in patients with stable coronary heart disease: data from the heart and soul study.

  2011cited by this paper
• Human resistin: found in translation from mouse to man.

  2011cited by this paper
• Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients

  2009cited by this paper
• The role of resistin as a regulator of inflammation: Implications for various human pathologies.

  2009cited by this paper
• Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study.

  2008cited by this paper
• Plasma resistin levels and risk of myocardial infarction and ischemic stroke.

  2008cited by this paper
• Serum resistin levels in Syrian obese patients with diabetes mellitus type II.

  2007cited by this paper
• Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus.

  2007cited by this paper
• Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke.

  2007cited by this paper
• Implications of resistin plasma levels in subjects undergoing coronary angiography

  2007cited by this paper
• Cross-sectional associations of resistin, coronary heart disease, and insulin resistance.

  2006cited by this paper
• Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes.

  2005cited by this paper
• The potential role of resistin in atherogenesis.

  2005cited by this paper
• High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.

  2004cited by this paper
• Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans

  2004cited by this paper
• Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes.

  2004cited by this paper
• Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions.

  2004cited by this paper
• Diabetes mellitus in Saudi Arabia.

  2004cited by this paper
• An Inflammatory Cascade Leading to Hyperresistinemia in Humans

  2004cited by this paper
• The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3.

  2004cited by this paper
• Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators.

  2003cited by this paper
• C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

  2000cited by this paper

• No citing papers are available for this paper.